Tectonic Therapeutic, Inc. ( TECX) - Key Metrics
TECX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.18 | -$1.13 | -$1.14 |
| 2026Q1 | $0 | -$1.34 | -$0.98 | -$0.98 |
| 2025Q4 | $0 | -$1.05 | -$0.79 | -$0.79 |
| 2025Q3 | $0 | -$1.02 | -$0.95 | -$0.96 |
| 2025Q2 | $0 | -$1.07 | -$0.79 | -$0.79 |
TECX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.28 |
| 2026Q1 | 0% | -5.77 |
| 2025Q4 | 0% | -5.06 |
| 2025Q3 | 0% | -3.85 |
| 2025Q2 | 0% | -4.64 |
TECX
Price: $36.05
52 week price:
Earnings Per Share: -4.57 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 720.0 million